5V7 Stock Overview
A medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Ventripoint Diagnostics Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.082 |
| 52 Week High | CA$0.24 |
| 52 Week Low | CA$0.077 |
| Beta | 0.39 |
| 11 Month Change | -7.91% |
| 3 Month Change | -40.51% |
| 1 Year Change | -19.31% |
| 33 Year Change | -65.17% |
| 5 Year Change | 64.65% |
| Change since IPO | -57.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5V7 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0.6% | 2.9% | 0.8% |
| 1Y | -19.3% | -4.7% | 8.6% |
Return vs Industry: 5V7 underperformed the German Medical Equipment industry which returned -5% over the past year.
Return vs Market: 5V7 underperformed the German Market which returned 9.1% over the past year.
Price Volatility
| 5V7 volatility | |
|---|---|
| 5V7 Average Weekly Movement | 15.2% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 5V7's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 5V7's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Hugh MacNaught | ventripoint.com |
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models.
Ventripoint Diagnostics Ltd. Fundamentals Summary
| 5V7 fundamental statistics | |
|---|---|
| Market cap | €14.83m |
| Earnings (TTM) | -€3.41m |
| Revenue (TTM) | €48.90k |
292.1x
P/S Ratio-4.2x
P/E RatioIs 5V7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5V7 income statement (TTM) | |
|---|---|
| Revenue | CA$72.07k |
| Cost of Revenue | CA$6.75k |
| Gross Profit | CA$65.32k |
| Other Expenses | CA$5.09m |
| Earnings | -CA$5.02m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.031 |
| Gross Margin | 90.64% |
| Net Profit Margin | -6,966.13% |
| Debt/Equity Ratio | -46.1% |
How did 5V7 perform over the long term?
See historical performance and comparison